Cleveland Clinic spinoff company to start clinical trials for Alzheimer’s disease

Cleveland Clinic spinoff company to start clinical trials for Alzheimer's disease

Cleveland Clinic spinoff company NeuroTherapia Inc. will start clinical trials of a new drug targeting inflammation of the brain that’s found in Alzheimer’s and other neurological diseases, according to a news release.

The U.S. Food and Drug Administration gave the company the go-ahead to begin its first in-human studies of the drug, NTRX-07, in an ascending dose study schedule to begin midsummer.

Click here to read the complete article.

Story excerpt provided by Crain’s Cleveland Business.

Written by Lydia Coutre.

Originally published April 22, 2019.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: